RSS   Newsletter   Contact   Advertise with us
Post Online Media

Gabriel Baertschi takes office as new CEO of Grünenthal Group

Gabriel BaertschiThe Grünenthal Group, a family-owned, research-based pharmaceutical company, announces that Gabriel Baertschi has taken office as new CEO of the Grünenthal Group.
Article continues below

READ MORE Grünenthal appoints Oscar Ferenczi to lead its Latin America business

Mr. Baertschi is joining Grünenthal from AstraZeneca, a global, science-led biopharmaceutical business where in his last appointment he served as country president for Japan.

Mr. Baertschi has more than 20 years of international experience in the pharmaceutical industry, including the last three years as country president for AstraZeneca K.K. when he was responsible for an organization of more than 3,000 employees across R&D, Manufacturing and Commercial functions.

Prior to taking up this role in 2013, he had served as country president for AstraZeneca Germany and earlier in his career served as country manager for AstraZeneca in various Emerging Markets.

Mr. Baertschi succeeds Prof. Dr. Eric-Paul Pâques who retires at the end of 2016 after 23 years at Grünenthal.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy